Rhythm Pharmaceuticals Appoints Dana Washburn, M.D., as Senior Vice President of…
BOSTON, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their…